Substance active (DCI)
- mirvetuximab soravtansine
Informations techniques
Présentation
ELAHERE 5 mg/mL, solution à diluer pour perfusion
1 flacon en verre de 20 mL (CIP : 34009 551 045 8 2)
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
VwL4qy43NcCY14xG
Écouter
09/04/2025
